The last few decades have seen a marked increase in mean life expectancy in
Central Europe. This has made elderly people and their quality of life a m
atter of ever-increasing medical concern. Available data from the United St
ates and Scandinavia relating to erectile dysfunction (ED) do not enable us
to draw valid conclusions about the current situation in Germany. The aim
of the present study was to evaluate the epidemiology of male sexuality in
Germany, and the proportion of men who need medical treatment because of in
creased suffering from this.
A newly developed and validated questionnaire on male erectile dysfunction
was mailed to a representative population sample of 8000 men, 30-80 y of ag
e in the Cologne urban district.
The response included 4489 evaluable replies (56.1%). The response rates in
different age groups ranged from 49.2% to 68.4%. Regular sexual activity w
as reported by 96.0% (youngest age group) to 71.3% (oldest group). There we
re 31.5%-44% of responders who were dissatisfied with their current sex lif
e. The prevalence of ED was 19.2%, with a steep age-related increase (2.3-5
3.4%) and a high co-morbidity of ED with hypertension, diabetes, pelvic sur
gery and 'lower urinary tract symptoms'. When treatment need was defined by
co-occurence of ED and dissatisfaction with sex life, 6.9% men required tr
eatment for ED. Oral treatment of ED was preferred by 73.8% of respondents.
There were 46.2% respondents who were willing to contribute more than DM 5
0 (25 Euro) per month for ED treatment.
We conclude that regular sexual activity is a normal finding in advanced ag
e. ED is a frequent disorder, contributing to dissatisfaction with sex life
in a considerable proportion of men. The high burden of ED is reflected in
willingness to pay for treatment. ED is frequently associated with chronic
diseases. Therefore adequate diagnostic workup is essential, to offer pati
ents individually adapted treatment. General non-reimbursability of treatme
nt for ED appears to be unacceptable.